Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 4190-4193, September 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leygue, E.
Right arrow Articles by Murphy, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leygue, E.
Right arrow Articles by Murphy, L. C.
[Cancer Research 59, 4190-4193, September 1, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Expression of the Steroid Receptor RNA Activator in Human Breast Tumors1

Etienne Leygue2, Helmut Dotzlaw, Peter H. Watson and Leigh C. Murphy

Departments of Biochemistry and Molecular Biology [E. L., H. D., L. C. M.] and Pathology [P. H. W.], University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, R3E OW3, Canada

The expression of the recently described steroid receptor RNA activator (SRA) was measured by semiquantitative reverse transcription-PCR within 27 independent breast tumors, spanning a wide spectrum of grade and estrogen receptor (ER) and progesterone receptor (PR) levels. Subgroup analysis showed that SRA expression was similar in ER+ /PR+ (median = 65.5, n = 8) and in ER-/PR- (median = 94.6, n = 5) tumors. Interestingly, SRA expression in these two subgroups was significantly (Mann-Whitney rank-sum test, P < 0.05) lower than that observed in ER+/PR- (median = 156.4, n = 6) and ER-/PR+ (median = 144.8, n = 8) tumors. A variant form of SRA, presenting a deletion of 203 bp within the SRA core sequence, was also observed in breast tumor tissues. The relative expression of this new SRA isoform correlated with tumor grade (Spearman coefficient r = 0.53, n = 27, P = 0.004). These data suggest that changes in the expression of SRA-related molecules occur during breast tumor progression.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
X. Zhao, J. R. Patton, S. K. Ghosh, N. Fischel-Ghodsian, L. Shen, and R. A. Spanjaard
Pus3p- and Pus1p-Dependent Pseudouridylation of Steroid Receptor RNA Activator Controls a Functional Switch that Regulates Nuclear Receptor Signaling
Mol. Endocrinol., March 1, 2007; 21(3): 686 - 699.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Gao, S. K. Mohsin, Z. Gatalica, G. Fu, P. Sharma, and Z. Nawaz
Decreased Expression of E6-Associated Protein in Breast and Prostate Carcinomas
Endocrinology, April 1, 2005; 146(4): 1707 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. L. Smith and B. W. O'Malley
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Endocr. Rev., February 1, 2004; 25(1): 45 - 71.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. B. Lanz, S. S. Chua, N. Barron, B. M. Soder, F. DeMayo, and B. W. O'Malley
Steroid Receptor RNA Activator Stimulates Proliferation as Well as Apoptosis In Vivo
Mol. Cell. Biol., October 15, 2003; 23(20): 7163 - 7176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Li, X. Yu, K. Ge, J. Melamed, R. G. Roeder, and Z. Wang
Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer
Am. J. Pathol., October 1, 2002; 161(4): 1467 - 1474.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z.-Q. Ma, Z. Liu, E. S. W. Ngan, and S. Y. Tsai
Cdc25B Functions as a Novel Coactivator for the Steroid Receptors
Mol. Cell. Biol., December 1, 2001; 21(23): 8056 - 8067.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. C. Stomper, C. C. Stewart, and D. L. Stoler
Stereotactic Core Biopsy Breast and Blood Cell By-products: A Source of Material for Molecular Genetics Research-Initial Experience
Radiology, March 1, 2001; 218(3): 881 - 885.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L. C. Murphy, S. L. R. Simon, A. Parkes, E. Leygue, H. Dotzlaw, L. Snell, S. Troup, A. Adeyinka, and P. H. Watson
Altered Expression of Estrogen Receptor Coregulators during Human Breast Tumorigenesis
Cancer Res., November 1, 2000; 60(22): 6266 - 6271.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. L. R. Simon, A. Parkes, E. Leygue, H. Dotzlaw, L. Snell, S. Troup, A. Adeyinka, P. H. Watson, and L. C. Murphy
Expression of a Repressor of Estrogen Receptor Activity in Human Breast Tumors: Relationship to Some Known Prognostic Markers
Cancer Res., June 1, 2000; 60(11): 2796 - 2799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-J. List, K. J. Lauritsen, R. Reiter, C. Powers, A. Wellstein, and A. T. Riegel
Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells
J. Biol. Chem., June 22, 2001; 276(26): 23763 - 23768.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.